List of Excipients in API DICLOFENAC POTASSIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DICLOFENAC POTASSIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | GELATIN | |
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | GLYCERIN | |
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | HYDROCHLORIC ACID | |
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | ISOPROPYL ALCOHOL | |
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | MINERAL OIL | |
| Assertio Therapeutics Inc | ZIPSOR | diclofenac potassium | 13913-008 | POLYETHYLENE GLYCOL 400 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DICLOFENAC POTASSIUM
Detailed excipient profiles for DICLOFENAC POTASSIUM
Excipient focus: ANHYDROUS LACTOSE
DICLOFENAC POTASSIUM drug variants containing ANHYDROUS LACTOSE
DICLOFENAC POTASSIUM drug variants not containing ANHYDROUS LACTOSE
Excipient focus: ASPARTAME
DICLOFENAC POTASSIUM drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | diclofenac potassium | 13913-011 |
| Par Pharmaceutical Inc | diclofenac potassium | 49884-905 |
| Nautilus Neurosciences Inc | diclofenac potassium | 50192-113 |
| Taro Pharmaceuticals USA Inc | diclofenac potassium | 51672-4240 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing ASPARTAME
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DICLOFENAC POTASSIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
DICLOFENAC POTASSIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COLLOIDAL SILICON DIOXIDE
DICLOFENAC POTASSIUM drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | diclofenac potassium | 21695-838 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
DICLOFENAC POTASSIUM drug variants containing CROSCARMELLOSE SODIUM
DICLOFENAC POTASSIUM drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C BLUE NO. 2
DICLOFENAC POTASSIUM drug variants containing FD&C BLUE NO. 2
DICLOFENAC POTASSIUM drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
DICLOFENAC POTASSIUM drug variants containing FD&C RED NO. 40
DICLOFENAC POTASSIUM drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
DICLOFENAC POTASSIUM drug variants containing FD&C YELLOW NO. 6
DICLOFENAC POTASSIUM drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
DICLOFENAC POTASSIUM drug variants containing FERRIC OXIDE RED
DICLOFENAC POTASSIUM drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
DICLOFENAC POTASSIUM drug variants containing FERRIC OXIDE YELLOW
DICLOFENAC POTASSIUM drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
DICLOFENAC POTASSIUM drug variants containing FERROSOFERRIC OXIDE
DICLOFENAC POTASSIUM drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
DICLOFENAC POTASSIUM drug variants containing GELATIN
DICLOFENAC POTASSIUM drug variants not containing GELATIN
Excipient focus: GLYCERIN
DICLOFENAC POTASSIUM drug variants containing GLYCERIN
DICLOFENAC POTASSIUM drug variants not containing GLYCERIN
Excipient focus: GLYCERYL BEHENATE
DICLOFENAC POTASSIUM drug variants containing GLYCERYL BEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Nautilus Neurosciences Inc | diclofenac potassium | 50192-113 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing GLYCERYL BEHENATE
Excipient focus: GLYCERYL BEHENATE/EICOSADIOATE
DICLOFENAC POTASSIUM drug variants containing GLYCERYL BEHENATE/EICOSADIOATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diclofenac potassium | 31722-046 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing GLYCERYL BEHENATE/EICOSADIOATE
Excipient focus: GLYCERYL DIBEHENATE
DICLOFENAC POTASSIUM drug variants containing GLYCERYL DIBEHENATE
DICLOFENAC POTASSIUM drug variants not containing GLYCERYL DIBEHENATE
Excipient focus: HYDROCHLORIC ACID
DICLOFENAC POTASSIUM drug variants containing HYDROCHLORIC ACID
DICLOFENAC POTASSIUM drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROLYSED BOVINE COLLAGEN
DICLOFENAC POTASSIUM drug variants containing HYDROLYSED BOVINE COLLAGEN
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing HYDROLYSED BOVINE COLLAGEN
Excipient focus: HYDROXYETHYL CELLULOSE
DICLOFENAC POTASSIUM drug variants containing HYDROXYETHYL CELLULOSE
DICLOFENAC POTASSIUM drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYPROMELLOSE
DICLOFENAC POTASSIUM drug variants containing HYPROMELLOSE
DICLOFENAC POTASSIUM drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
DICLOFENAC POTASSIUM drug variants containing HYPROMELLOSE 2910
DICLOFENAC POTASSIUM drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
DICLOFENAC POTASSIUM drug variants containing HYPROMELLOSES
DICLOFENAC POTASSIUM drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
DICLOFENAC POTASSIUM drug variants containing INDIGOTINDISULFONATE SODIUM
DICLOFENAC POTASSIUM drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: ISOPROPYL ALCOHOL
DICLOFENAC POTASSIUM drug variants containing ISOPROPYL ALCOHOL
DICLOFENAC POTASSIUM drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTIC ACID
DICLOFENAC POTASSIUM drug variants containing LACTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing LACTIC ACID
Excipient focus: LACTOSE MONOHYDRATE
DICLOFENAC POTASSIUM drug variants containing LACTOSE MONOHYDRATE
DICLOFENAC POTASSIUM drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
DICLOFENAC POTASSIUM drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
DICLOFENAC POTASSIUM drug variants containing MAGNESIUM STEARATE
DICLOFENAC POTASSIUM drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
DICLOFENAC POTASSIUM drug variants containing MANNITOL
DICLOFENAC POTASSIUM drug variants not containing MANNITOL
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
DICLOFENAC POTASSIUM drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
DICLOFENAC POTASSIUM drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHYL ALCOHOL
DICLOFENAC POTASSIUM drug variants containing METHYL ALCOHOL
DICLOFENAC POTASSIUM drug variants not containing METHYL ALCOHOL
Excipient focus: MINERAL OIL
DICLOFENAC POTASSIUM drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | diclofenac potassium | 13913-008 |
| Leading Pharma LLC | diclofenac potassium | 69315-275 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing MINERAL OIL
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
DICLOFENAC POTASSIUM drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
DICLOFENAC POTASSIUM drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
Excipient focus: PEPPERMINT
DICLOFENAC POTASSIUM drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diclofenac potassium | 31722-046 |
| Par Pharmaceutical Inc | diclofenac potassium | 49884-905 |
| Ascend Laboratories LLC | diclofenac potassium | 67877-772 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing PEPPERMINT
Excipient focus: POLACRILIN POTASSIUM
DICLOFENAC POTASSIUM drug variants containing POLACRILIN POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | diclofenac potassium | 49884-905 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing POLACRILIN POTASSIUM
Excipient focus: POLYDEXTROSE
DICLOFENAC POTASSIUM drug variants containing POLYDEXTROSE
DICLOFENAC POTASSIUM drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
DICLOFENAC POTASSIUM drug variants containing POLYETHYLENE GLYCOL
DICLOFENAC POTASSIUM drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
DICLOFENAC POTASSIUM drug variants containing POLYETHYLENE GLYCOL 400
DICLOFENAC POTASSIUM drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
DICLOFENAC POTASSIUM drug variants containing POLYETHYLENE GLYCOL 4000
DICLOFENAC POTASSIUM drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 8000
DICLOFENAC POTASSIUM drug variants containing POLYETHYLENE GLYCOL 8000
DICLOFENAC POTASSIUM drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
DICLOFENAC POTASSIUM drug variants containing POLYSORBATE 80
DICLOFENAC POTASSIUM drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ACETATE PHTHALATE
DICLOFENAC POTASSIUM drug variants containing POLYVINYL ACETATE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing POLYVINYL ACETATE PHTHALATE
Excipient focus: POTASSIUM BICARBONATE
DICLOFENAC POTASSIUM drug variants containing POTASSIUM BICARBONATE
DICLOFENAC POTASSIUM drug variants not containing POTASSIUM BICARBONATE
Excipient focus: POVIDONE
DICLOFENAC POTASSIUM drug variants containing POVIDONE
DICLOFENAC POTASSIUM drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
DICLOFENAC POTASSIUM drug variants containing POVIDONE K30
DICLOFENAC POTASSIUM drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
DICLOFENAC POTASSIUM drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Aidarex Pharmaceuticals LLC | diclofenac potassium | 33261-038 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
DICLOFENAC POTASSIUM drug variants containing PROPYLENE GLYCOL
DICLOFENAC POTASSIUM drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
DICLOFENAC POTASSIUM drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | diclofenac potassium | 13913-011 |
| Par Pharmaceutical Inc | diclofenac potassium | 49884-905 |
| Nautilus Neurosciences Inc | diclofenac potassium | 50192-113 |
| Taro Pharmaceuticals USA Inc | diclofenac potassium | 51672-4240 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing SACCHARIN SODIUM
Excipient focus: SHELLAC
DICLOFENAC POTASSIUM drug variants containing SHELLAC
DICLOFENAC POTASSIUM drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
DICLOFENAC POTASSIUM drug variants containing SILICON DIOXIDE
DICLOFENAC POTASSIUM drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BICARBONATE
DICLOFENAC POTASSIUM drug variants containing SODIUM BICARBONATE
DICLOFENAC POTASSIUM drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
DICLOFENAC POTASSIUM drug variants containing SODIUM LAURYL SULFATE
DICLOFENAC POTASSIUM drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
DICLOFENAC POTASSIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
DICLOFENAC POTASSIUM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITAN
DICLOFENAC POTASSIUM drug variants containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing SORBITAN
Excipient focus: SORBITOL
DICLOFENAC POTASSIUM drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| Assertio Therapeutics Inc | diclofenac potassium | 13913-008 |
| Aurobindo Pharma Limited | diclofenac potassium | 59651-353 |
| Leading Pharma LLC | diclofenac potassium | 69315-275 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
DICLOFENAC POTASSIUM drug variants containing STARCH, CORN
DICLOFENAC POTASSIUM drug variants not containing STARCH, CORN
Excipient focus: SUCRALOSE
DICLOFENAC POTASSIUM drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Assertio Therapeutics Inc | diclofenac potassium | 13913-012 |
| Camber Pharmaceuticals Inc | diclofenac potassium | 31722-046 |
| Ascend Laboratories LLC | diclofenac potassium | 67877-772 |
| Leading Pharma LLC | diclofenac potassium | 69315-506 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing SUCRALOSE
Excipient focus: TALC
DICLOFENAC POTASSIUM drug variants containing TALC
DICLOFENAC POTASSIUM drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
DICLOFENAC POTASSIUM drug variants containing TITANIUM DIOXIDE
DICLOFENAC POTASSIUM drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
DICLOFENAC POTASSIUM drug variants containing TRIACETIN
DICLOFENAC POTASSIUM drug variants not containing TRIACETIN
Excipient focus: TRIBASIC CALCIUM PHOSPHATE
DICLOFENAC POTASSIUM drug variants containing TRIBASIC CALCIUM PHOSPHATE
DICLOFENAC POTASSIUM drug variants not containing TRIBASIC CALCIUM PHOSPHATE
Excipient focus: TRIBASIC SODIUM PHOSPHATE
DICLOFENAC POTASSIUM drug variants containing TRIBASIC SODIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | diclofenac potassium | 31722-046 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing TRIBASIC SODIUM PHOSPHATE
Excipient focus: TRICALCIUM PHOSPHATE
DICLOFENAC POTASSIUM drug variants containing TRICALCIUM PHOSPHATE
DICLOFENAC POTASSIUM drug variants not containing TRICALCIUM PHOSPHATE
Excipient focus: WATER
DICLOFENAC POTASSIUM drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| TEVA PHARMACEUTICALS INC | diclofenac potassium | 0480-9435 |
| Aurobindo Pharma Limited | diclofenac potassium | 59651-353 |
| >Company | >Ingredient | >NDC |
DICLOFENAC POTASSIUM drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
